Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10519411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.

  1999cited by this paper
• The murine gene p27Kip1 is haplo-insufficient for tumour suppression

  1998cited by this paper
• Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality

  1998cited by this paper
• Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2.

  1998cited by this paper
• Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

  1998cited by this paper
• Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

  1998cited by this paper
• Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

  1998cited by this paper
• Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

  1998cited by this paper
• Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.

  1998cited by this paper
• Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.

  1998cited by this paper
• Genetics and ovarian carcinoma.

  1998cited by this paper
• Allelic loss and prognosis in carcinoma of the uterine cervix

  1998cited by this paper
• Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers

  1998cited by this paper
• DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

  1998cited by this paper
• Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

  1998cited by this paper
• Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.

  1998cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.

  1998cited by this paper
• Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.

  1998cited by this paper
• Regulation of Cyclin D1 by Calpain Protease*

  1997cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

  1997cited by this paper
• Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas

  1997cited by this paper
• Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours

  1997cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

  1997cited by this paper
• Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

  1997cited by this paper
• Reduced Expression of Cyclin–dependent Kinase Inhibitor p27Kipl Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas

  1997cited by this paper
• Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells.

  1997cited by this paper
• Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

  1997cited by this paper
• Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours

  1997cited by this paper
• Deletion within the D17S34 locus in a primitive neuroectodermal tumor.

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

  1997cited by this paper
• Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors

  1997cited by this paper
• Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells.

  1996cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Allelic deletion on chromosome 17p13.3 in early ovarian cancer.

  1996cited by this paper
• p27/Kip1 mutation found in breast cancer.

  1996cited by this paper
• A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3.

  1996cited by this paper
• p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.

  1996cited by this paper
• Identification of two candidate tumor suppressor genes on chromosome 17p13.3.

  1996cited by this paper
• DPC4 gene in various tumor types.

  1996cited by this paper
• No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma

  1995cited by this paper
• Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.

  1995cited by this paper
• Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.

  1995cited by this paper
• Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.

  1995cited by this paper
• Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.

  1995cited by this paper
• Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system

  1995cited by this paper
• Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors.

  1995cited by this paper
• Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.

  1995cited by this paper
• Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma.

  1995cited by this paper
• D-type cyclins.

  1995cited by this paper
• Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.

  1994cited by this paper
• Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations

  1994cited by this paper
• Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

  1994cited by this paper
• p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.

  1993cited by this paper
• Diphthamide synthesis in Saccharomyces cerevisiae: structure of the DPH2 gene.

  1993cited by this paper
• Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

  1993cited by this paper
• Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers

  1993cited by this paper
• Allelic loss on chromosome 17 in human ovarian cancer

  1993cited by this paper
• Human breast cancer: frequent p53 allele loss and protein overexpression

  1993cited by this paper
• Cyclin D and oncogenesis.

  1993cited by this paper
• Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.

  1992cited by this paper
• Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.

  1992cited by this paper
• Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.

  1992cited by this paper
• Infrequent p53 gene mutations in medulloblastomas.

  1991cited by this paper
• Suppression of human colorectal carcinoma cell growth by wild-type p53.

  1990cited by this paper
• Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

  1990cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Wild-type p53 can inhibit oncogene-mediated focus formation.

  1989cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• Chromosome 17p loss in carcinoma of the cervix uteri.

  1989cited by this paper
• ALLELE LOSSES IN BREAST CANCER

  1989cited by this paper
• Allele loss on short arm of chromosome 17 in breast cancers.

  1988cited by this paper
• Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

  1988cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• Guardians of the Genome: Iron–Sulfur Proteins in the Nucleus

  2024cites this paper
• 17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas

  2024cites this paper
• Diphthamide - a conserved modification of eEF2 with clinical relevance.

  2023cites this paper
• The functional variant in promoter of OVCA1 was associated with the risk of gastric cancer in the northeast Chinese Han population.

  2021cites this paper
• Diphthamide

  2020cites this paper
• Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.

  2019cites this paper
• The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway

  2018influential citation
• Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADP-Ribosylating Toxins

  2017influential citation
• Diphthamide Biosynthesis 1 is a Novel Oncogene in Colorectal Cancer Cells and is Regulated by MiR-218-5p

  2017cites this paper
• OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia

  2017cites this paper
• The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups

  2016cites this paper
• A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells

  2015cites this paper
• Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types

  2014cites this paper
• The biosynthesis and biological function of diphthamide

  2013cites this paper
• A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene*

  2013cites this paper
• Molecular mechanisms underlying the neuroprotective effect of IGF-1 in neuroblastoma cells and the pro-metastatic effect of Dph3 in murine melanoma cells

  2013cites this paper
• New genes involved in the synthesis of diphthamide, a modification of eukaryotic translation elongation factor 2 with roles in diphtheria disease and ovarian cancer formation

  2013cites this paper
• Characterization of distinct molecular genetic alterations in BRAF and NRAS mutated human primary melanoma

  2013cites this paper
• FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome.

  2013cites this paper
• Proteomics analysis of in vitro protein methylation during Src‐induced transformation

  2012cites this paper
• The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

  2012cites this paper
• Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma

  2012cites this paper
• Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization

  2012cites this paper
• OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16

  2011cites this paper
• Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization

  2011cites this paper
• Unique modifications of translation elongation factors

  2011cites this paper
• Biomarker targets and novel therapeutics.

  2009cites this paper
• Tumor suppressor genes.

  2009cites this paper
• Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.

  2008cites this paper
• Molecular and transcriptional characterization of 17p loss in B‐cell chronic lymphocytic leukemia

  2008cites this paper
• Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality

  2008cites this paper
• Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY.

  2006cites this paper
• White Spot Syndrome Virus Open Reading Frame 222 Encodes a Viral E3 Ligase and Mediates Degradation of a Host Tumor Suppressor via Ubiquitination

  2006cites this paper
• Characterization of γ-Aminobutyric Acid Type A Receptor–Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer

  2005cites this paper
• High throughput functional genomics: Identification of novel genes with tumor suppressor phenotypes

  2005cites this paper
• Gene Trap Mutagenesis-based Forward Genetic Approach Reveals That the Tumor Suppressor OVCA1 Is a Component of the Biosynthetic Pathway of Diphthamide on Elongation Factor 2*

  2005cites this paper
• Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.

  2005cites this paper
• Reduced Expression in Breast Cancer Associated Protein , a Novel Tumor Suppressor , Showing −-Aminobutyric Acid Type A Receptor γ Characterization of Updated

  2005cites this paper
• Chapter 28 – Molecular Biology and Molecular Genetics of Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

  2004cites this paper
• Identification of the Proteins Required for Biosynthesis of Diphthamide, the Target of Bacterial ADP-Ribosylating Toxins on Translation Elongation Factor 2

  2004cites this paper
• OVCA1: emerging as a bona fide tumor suppressor.

  2004influential citation
• Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.

  2004cites this paper
• Regulation of Drosophila Hypoxia-inducible Factor (HIF) Activity in SL2 Cells

  2004cites this paper
• Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.

  2004cites this paper
• The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis.

  2003cites this paper
• TP53 and ovarian cancer

  2003cites this paper
• Specific keynote: molecular therapeutics in ovarian cancer.

  2003cites this paper
• Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

  2003cites this paper
• OVCA2 is downregulated and degraded during retinoid‐induced apoptosis

  2002cites this paper
• High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.

  2002cites this paper
• DNA array‐based method for detection of large rearrangements in the BRCA1 gene

  2002cites this paper
• Tumour suppressor genes in sporadic epithelial ovarian cancer.

  2002cites this paper
• OVCA 2I SDOWNREGULATE DAN DDEGRADE DDURIN GRETINOID-INDUCED APOPTOSIS

  2002cites this paper
• LCRG1 suppresses tumor growth in vivo by liposome-mediated gene transfer

  2002cites this paper
• Identification of genes induced by BRCA1 in breast cancer cells.

  2002cites this paper
• Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas

  2001cites this paper
• Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs

  2001cites this paper
• Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters

  2001cites this paper
• Cloning, structure, and expression of the mouse Ovca1 gene.

  2001cites this paper
• Identification in the Human Candidate Tumor Suppressor GeneHIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53*

  2001cites this paper
• Aberran tHypermethylatio no fth eMajo rBreakpoint Cluste rRegio ni n17p11. 2i nMedulloblastoma sbut no tSupratentoria lPNETs

  2001cites this paper
• Genetic factors in ovarian carcinoma

  2001cites this paper
• Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27

  2001cites this paper
• Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

  2000cites this paper
• Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.

  2000cites this paper
• Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor.

  2000cites this paper